Galimi Francesco's most recent trade in Adicet Bio Inc was a trade of 375,077 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 05 Jun 2024 | 375,077 | 375,077 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 24 Jan 2024 | 288,134 | 288,134 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Galimi Francesco | SVP & Chief Medical Officer | 24 Jan 2024 | 26,300 | 101,801 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Galimi Francesco | SVP & Chief Medical Officer | 24 Jan 2024 | 4,957 | 75,501 | - | 2.4 | 11,897 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 117,200 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 117,200 | 117,200 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 113,652 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 113,652 | 113,652 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 77,269 | 77,269 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 77,269 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 73,964 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 73,964 | 73,964 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 26,625 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Aug 2023 | 26,625 | 26,625 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 24 Jan 2023 | 117,200 | 117,200 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 24 Jan 2023 | 26,100 | 88,551 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 04 Oct 2022 | 7,933 | 62,451 | - | 14.2 | 112,807 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 04 Aug 2022 | 16,000 | 75,917 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 04 Aug 2022 | 5,533 | 70,384 | - | 18.2 | 100,977 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 7,621 | 67,538 | - | 6.0 | 45,497 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 7,621 | 59,917 | - | 21 | 160,041 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 7,621 | 113,820 | - | - | Employee Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 6,036 | 59,917 | - | 21 | 126,756 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 6,036 | 65,953 | - | 13.3 | 80,098 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 6,036 | 73,964 | - | - | Employee Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 1,775 | 59,917 | - | 21 | 37,275 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 1,775 | 61,692 | - | 16.8 | 29,856 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 1,775 | 26,625 | - | - | Employee Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 168 | 59,917 | - | 21 | 3,528 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 168 | 60,085 | - | 6.0 | 1,003 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Apr 2022 | 168 | 113,652 | - | - | Employee Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Feb 2022 | 16,000 | 65,450 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 14 Feb 2022 | 5,533 | 59,917 | - | 14.3 | 78,956 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 28 Jan 2022 | 16,000 | 54,983 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 28 Jan 2022 | 5,533 | 49,450 | - | 11.7 | 64,681 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 07 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 01 Oct 2021 | 80,000 | 86,983 | - | 0 | Common Stock | ||
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 04 Jun 2021 | 6,983 | 6,983 | - | 6.0 | 41,689 | Common Stock | |
| Adicet Bio Inc | Francesco Galimi | SVP & Chief Medical Officer | 04 Jun 2021 | 6,983 | 121,441 | - | - | Employee Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | See Remarks | 12 Feb 2021 | 28,400 | 28,400 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Francesco Galimi | See Remarks | 13 Jan 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |